Key result
Pre-discharge normalized electromechanical activation time (%EMAT) significantly predicted post-discharge cardiovascular events in acute heart failure patients, with a hazard ratio of 1.87 per 1-SD increment.
Why the study?
Does electromechanical activation time (EMAT) predict cardiovascular mortality or heart failure re-hospitalization in patients hospitalized with acute heart failure syndrome?
Cohort (n=45)
Single-blind
No
Does electromechanical activation time (EMAT) predict cardiovascular mortality or heart failure re-hospitalization in patients hospitalized with acute heart failure syndrome?
Electromechanical activation time (EMAT) measured during hospitalization for acute heart failure is a significant, independent predictor of post-discharge cardiovascular mortality and re-hospitalization.
May aid post-discharge risk stratification in acute HF; extends noninvasive predictors but remains hypothesis-generating.
OBJECTIVE: Left ventricular systolic time intervals, including pre-ejection period (PEP), ejection time (ET), and their ratio (PEP/ET), is determined by systolic and diastolic function and ventriculo-arterial coupling. We investigated the usefulness of the electromechanical activation time [(EMAT) PEP minus isovolumic contraction time] in the prediction of cardiac mortality or re-hospitalization for heart failure in patients with the acute heart failure syndrome (AHFS). PATIENTS AND METHODS: A total of 45 patients (71.9±16.1 years old) hospitalized for AHFS were enrolled. Systolic time intervals and EMAT normalized by cardiac cycle length (%) were measured separately by separate automated acoustic devices. All parameters were assessed within 24 hours of admission, before discharge, and 2 weeks after discharge. RESULTS: During a mean follow-up of 242±156 days, 20 patients (44%) incurred adverse cardiovascular events including 18 re-hospitalizations for heart failure and 2 cardiovascular deaths. Using uni-variate Cox regression analysis, at admission %EMAT and %PEP, pre-discharge %EMAT, and post-discharge %EMAT significantly predicted post-discharge cardiovascular events with hazard ratios and 95% confidence intervals of 1.75 (1.13-2.70), 1.67 (1.02-2.70), 1.87 (1.10-3.17) and 2.50 (1.58-3.97) per 1-SD increment, respectively. The predictions remained significant after adjustment for age, sex, left ventricular ejection fraction, E/E´ by Doppler echocardiography, and serum N-terminal pro-brain natriuretic peptide. CONCLUSION: EMAT measured during the hospitalization course is useful in the prediction of cardiovascular outcomes in patients with AHFS independent of left ventricular ejection fraction, E/E´, and serum N-terminal pro-brain natriuretic peptide.
No takes yet. Share an insight, caveat, or question.
Chao et al. (2010) conducted a cohort in Acute heart failure syndrome (n=45). Normalized electromechanical activation time (%EMAT) vs. Lower %EMAT was evaluated on Post-discharge cardiovascular events (re-hospitalization for heart failure or cardiovascular death) (HR 1.87, 95% CI 1.10-3.17, p=0.021). Pre-discharge normalized electromechanical activation time (%EMAT) significantly predicted post-discharge cardiovascular events in acute heart failure patients, with a hazard ratio of 1.87 per 1-SD increment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: